openPR Logo
Press release

Venous Stents Market to Expand at a CAGR of 9.7% From 2025 - Boston Scientific, C. R Bard, Jotech GMBH, Cook, W.L Gore & Associates, optimed Medizinische Instrumente GMBH, Medtronic, Medica Germany GMBH & Co. KG and Cordis

02-22-2019 08:18 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Venous Stents Market at CAGR of 9.7% from 2018-2025

Venous Stents Market at CAGR of 9.7% from 2018-2025

Worldwide Venous Stents Market Analysis to 2025 is a specialized and in-depth study of the Venous Stents Industry with a focus on the global market trend. The report aims to provide an overview of global Venous Stents Market with detailed market segmentation by product/application and geography. The global Venous Stents Market is expected to witness high growth during the forecast period. The report provides key statistics on the Market status of the Venous Stents players and offers key trends and opportunities in the market.

Venous Stents Market is expected to reach US$ 1,727.4 Mn in 2025 from US$ 829.0 Mn in 2017. The market is estimated to grow with a CAGR of 9.7% from 2018-2025. The report highlights the trends prevalent in the global venous stents market and the factors driving the market.

The major players operating in the venous stents market includes Boston Scientific Corporation, C. R Bard (acquired by BD), Jotech GMBH (acquired by Cryolife, Inc.), Cook, W.L Gore & Associates, Optimed Medizinische Instrumente GMBH, Medtronic, Medica Germany GMBH & Co. KG, and Cordis (acquired by Cardinal Health).

Get PDF Sample Copy of this Report @ http://bit.ly/2EqKmJE

Global venous stents market, based on technology was segmented into wallstent technology and iliac vein stent technology. In 2017, iliac vein stent technology segment held the largest share of the market, by technology. Whereas, the wallstent technology segment is reported to be the fastest growing of the market as enabling the healthcare practitioners to precisely place the stent and also allows minute repositioning of the stent which eventually ensures good blood flow. Furthermore, venous stent technology is advancing with market players developing dedicated venous stents and frequent launches.

For instance, Medtronic launched Abre venous stent in December 2017 to treat symptomatic venous outflow obstruction. Therefore, these technological advancements are capable for treating patients suffering from chronic venous disease. Thus, owing to these factors the rise in the segment for the venous stents market is likely to enhance the growth of the market in the coming years.

Key questions answered in the report include:

• what will the market size and the growth rate be in 2025?
• what are the key factors driving the global Patient Simulators Market?
• what are the key market trends impacting the growth of the Patient Simulators Market?
• what are the challenges to market growth?
• who are the key vendors in this market space?

The market for venous stents market is expected to grow due to the rising prevalence of venous diseases, technological advancement in stent technology and rising global geriatric population. The market is likely to get impacted due to the restraining factors such as stringent regulations for approval and high cost of surgical procedures. The market players have an opportunity to grow in the emerging nations whereas the trend in the development of advanced venous stents are likely to boost the market in the coming future.

The report segments the global venous stents market as follows:

Global Venous Stents Market - By Technology

• Wallstent Technology,
• Iliac Vein Stent Technology

Global Venous Stents Market - By Application

• Legs
• Chest
• Abdomen

Global Venous Stents Market - By Disease

• Post Thrombotic Syndrome,
• Chronic Deep Vein Thrombosis,
• May-Thurner Syndrome,
• Hemodialysis/Arteriovenous Fistulae, and
• Others

Enquiry for Discount @ http://bit.ly/2SUkrTv

What our report offers:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global Venous Stents Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Venous Stents, thereby allowing players to develop effective long term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Venous Stents Market to Expand at a CAGR of 9.7% From 2025 - Boston Scientific, C. R Bard, Jotech GMBH, Cook, W.L Gore & Associates, optimed Medizinische Instrumente GMBH, Medtronic, Medica Germany GMBH & Co. KG and Cordis here

News-ID: 1611349 • Views:

More Releases from The Insight Partners

Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
3D orthopaedic scanning devices are sophisticated technology-driven systems used to scan human body components for the detection and treatment of the defect. By means of its scanning capabilities, 3D orthopaedic scanning systems help to design uniquely customised products and to find further use in surgical procedures. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00017457/?utm_source=OpenPR&utm_medium=10129 Orthopedic 3D Scanners Market: Competitive Landscape and Key Developments: • Delcam Plc • Allied OSI Labs • SCANNY3D S.r.l. • AGE Solutions S.r.l. • Orthopaedic Innovation Centre • Diasu
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate cancer diagnostics refers to the various tests and procedures used to diagnose prostate cancer in men. Early detection of prostate cancer is important for successful treatment and recovery. Several different diagnostic tests are available, including digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. With the increasing prevalence of prostate cancer. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003656/?utm_source=OpenPR&utm_medium=10129 Prostate Cancer Diagnostics Market: Competitive Landscape and Key Developments: • MDxHealth • Telo Genomics Corp
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, O …
The Aerospace Plastics Market report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation. Get Sample Copy of Report at: https://www.theinsightpartners.com/sample/TIPRE00005464/?utm_source=OpenPR&utm_medium=10188 Companies Profiled in this report includes: • SABIC • Victrex • Drake Plastics Ltd • Solvay • BASF SE • Evonik Industries AG • Vantage Plane Plastics • Paco Plastics & Engineering Inc. • 3P • Performance Plastics Products • Big Bear Plastics The report scrutinizes different business approaches and frameworks that
Consumer Genomics: A Guide to Understanding the Process
Consumer Genomics: A Guide to Understanding the Process
Consumer genomics market is growing as it is very frictionless. A patient can purchase a genetic test online and then receive a test kit by mail and collect a DNA sample in their own home. Patients will receive the results at home and don't need any guidance of a genetic counselor or medical practitioner. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006429/?utm_source=OpenPR&utm_medium=10129 Consumer Genomics Market: Competitive Landscape and Key Developments: •

All 5 Releases


More Releases for Stent

Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients
Gel Stent Markets- gel stent market include AqueSysInc. and ALLERGAN.
The Zion Market Research added a new report “Gel Stent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting. Gel Stent Market Market research report which provides an in-depth examination of the market scenario regarding market size, share,
Global Coronary Stent Grafts Market to Observe Strong Development during the For …
In the recent decades the number of myocardial revascularization procedures, incorporating coronary angioplasty, in chronic stable angina (CSA) patients has grown significantly. Irrespective of various innovations in coronary angioplasty techniques that require coronary stent grafts, recurrent angina post coronary angioplasty has become a frequent medical issue that many cardiologists in clinical practice have to face. The plight has turned so worse that over 30% of patients with prior revascularization still